0 CHECKOUT

Belgium Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

  • ID: 1053532
  • June 2009
  • Region: Belgium
  • 111 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • ARKRAY, Inc.
  • Eli Lilly and Company
  • LifeScan, Inc.
  • Novo Nordisk A/S
  • Smiths Medical
  • MORE

Belgium Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Belgium diabetes care devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the diabetes care devices market in Belgium

Scope

- The report provides diabetes care devices information broken down into detailed categories and segments in Belgium.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • ARKRAY, Inc.
  • Eli Lilly and Company
  • LifeScan, Inc.
  • Novo Nordisk A/S
  • Smiths Medical
  • MORE

1
1

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of Markets Covered in the Report
3.1 Diabetes Care Devices
3.2 Glucose Monitoring Devices
3.2.1 Blood Glucose Meters
3.2.2 Blood Glucose Strips
3.3 Insulin Delivery
3.3.1 Insulin Pens
3.3.2 Insulin Syringes
3.3.3 Insulin Pumps
3.3.4 Traditional Insulin Pump Accessories
4 Healthcare Sector Review
4.1 Healthcare Expenditure
4.2 Healthcare Infrastructure
4.2.1 Healthcare Personnel Data
4.2.2 Healthcare Facilities Data
4.3 Healthcare Policy
5 Regulation System
5.1 Medical Equipment Approval Process
5.1.1 Classification
5.1.2 Conformity Assessment Process
5.2 Notification Fee
6 Pricing and Reimbursement
6.1 Reimbursement Policies
7 Distribution Structure
8 Diabetes Care Devices In Belgium
8.1 Diabetes Care Devices, Belgium, Overall Revenue ($ mn), 2000-2015
8.2 Diabetes Care Devices, Belgium, Category Volume (Units), 2000-2015
8.3 Diabetes Care Devices, Belgium, Company Share (2007-2008)
9 Glucose Monitoring In Belgium
9.1 Glucose Monitoring Overall Revenue (2000-2015)
9.1.1 Blood Glucose Meters Revenue (2000-2015)
9.2 Glucose Monitoring Overall Volume (2000-2015)
9.2.1 Blood Glucose Meters Volume (2000-2015)
9.3 Glucose Monitoring Average Price (2000-2015)
9.4 Glucose Monitoring Distribution Share (2007-2008)
9.5 Glucose Monitoring, Belgium, Company Share (2007-2008)
10 Insulin Delivery In Belgium
10.1 Insulin Delivery Overall Revenue (2000-2015)
10.1.1 Insulin Pens Revenue (2000-2015)
10.2 Insulin Delivery Overall Volume (2000-2015)
10.2.1 Insulin Pens Volume (2000-2015)
10.3 Insulin Delivery Average Price (2000-2015)
10.4 Insulin Delivery Distribution Share (2007-2008)
10.5 Insulin Delivery, Belgium, Company Share (2007-2008)
11 Overview of Key Companies in Belgium Diabetes Care Devices Market
11.1 Terumo Corporation
11.1.1 Company Overview
11.1.2 Value Chain Analysis
11.2 Smiths Medical
11.2.1 Company Overview
11.2.2 Value Chain Analysis
11.3 Sanofi-Aventis
11.3.1 Company Overview
11.4 Novo Nordisk A/S
11.4.1 Company Overview
11.4.2 Novo Nordisk A/S Pipeline Products
11.5 Medtronic, Inc.
11.5.1 Company Overview
11.5.2 Value Chain Analysis
11.5.3 Medtronic, Inc. Pipeline Products
11.6 LifeScan, Inc.
11.6.1 Company Overview
11.6.2 LifeScan, Inc. Pipeline Products
11.7 F. Hoffmann-La Roche Ltd.
11.7.1 Company Overview
11.7.2 Value Chain Analysis
11.7.3 F. Hoffmann-La Roche Ltd Pipeline Products
11.8 Eli Lilly and Company
11.8.1 Company Overview
11.8.2 Value Chain Analysis
11.8.3 Eli Lilly and Company Pipeline Products
11.9 Becton, Dickinson and Company
11.9.1 Company Overview
11.9.2 Value Chain Analysis
11.10 Bayer HealthCare AG
11.10.1 Company Overview
11.10.2 Value Chain Analysis
11.10.3 Bayer HealthCare AG Pipeline Products
11.11 ARKRAY, Inc.
11.11.1 Company Overview
11.11.2 ARKRAY, Inc. Pipeline Products
11.12 Animas Corporation
11.12.1 Company Overview
11.13 Abbott Laboratories
11.13.1 Company Overview
11.13.2 Value Chain Analysis
11.13.3 Abbott Laboratories Pipeline Products
12 Appendix
12.1 Global Markets Direct Research Methodology
12.2 Coverage
12.3 Secondary Research
12.4 Primary Research
12.5 Models
12.6 Forecasts
12.7 Expert Panel Validation
12.8 Currency Conversion
12.9 Contact Us
12.10 Disclaimer

Executive Summary

1.1 List of Tables
Table 1: Hospitals and Hospital Beds in Belgium, 2005 15
Table 2: Number of Doctors by Specialty in Belgium, 2003-2007 16
Table 3: Number of Hospital Wards by Specialty in Belgium, 2003-2007 17
Table 4: Medical Equipment Notification Fee in Belgium, 2007 34
Table 5: Diabetes Care Devices, Belgium, Overall Revenue ($ mn), 2000-2015 37
Table 6: Diabetes Care Devices, Belgium, Cross-Category Analysis, 2000-2015 38
Table 7: Diabetes Care Devices, Belgium, Overall Revenue ($ mn), Historic, 2000-2008 39
Table 8: Diabetes Care Devices, Belgium, Overall Revenue ($ mn), Forecast, 2008-2015 40
Table 9: Diabetes Care Devices, Belgium, Category Volume (Units), 2000-2015 41
Table 10: Diabetes Care Devices, Belgium, Category Volume (Units), Historic, 2000-2008 42
Table 11: Diabetes Care Devices, Belgium, Category Volume (Units), Forecast, 2008-2015 43
Table 12: Diabetes Care Devices, Belgium, Company Share by Revenue ($ mn), 2007-2008 44
Table 13: Glucose Monitoring, Belgium, Revenue ($ mn) by Segment, Historic, 2000-2008 45
Table 14: Glucose Monitoring, Belgium, Revenue ($ mn) by Segment, Forecast, 2008-2015 46
Table 15: Blood Glucose Meters, Belgium, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 47
Table 16: Blood Glucose Meters, Belgium, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 48
Table 17: Glucose Monitoring, Belgium, Volume (Units) by Segment, Historic, 2000-2008 49
Table 18: Glucose Monitoring, Belgium, Volume (Units) by Segment, Forecast, 2008-2015 50
Table 19: Blood Glucose Meters, Belgium, Volume (Units) by Sub-Segment, Historic, 2000-2008 51
Table 20: Blood Glucose Meters, Belgium, Volume (Units) by Sub-Segment, Forecast, 2008-2015 51
Table 21: Glucose Monitoring, Belgium, Average Price ($), Historic, 2000-2008 52
Table 22: Glucose Monitoring, Belgium, Average Price ($), Forecast, 2008-2015 52
Table 23: Glucose Monitoring, Belgium, Distribution Share by Revenue ($mn), 2007-2008 53
Table 24: Glucose Monitoring, Belgium, Company Share by Revenue ($ mn), 2007-2008 54
Table 25: Insulin Delivery, Belgium, Revenue ($ mn) by Segment, Historic, 2000-2008 55
Table 26: Insulin Delivery, Belgium, Revenue ($ mn) by Segment, Forecast, 2008-2015 56
Table 27: Insulin Pens, Belgium, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 57
Table 28: Insulin Pens, Belgium, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 58
Table 29: Insulin Delivery, Belgium, Volume (Units) by Segment, Historic, 2000-2008 59
Table 30: Insulin Delivery, Belgium, Volume (Units) by Segment, Forecast, 2008-2015 59
Table 31: Insulin Pens, Belgium, Volume (Units) by Sub-Segment, Historic, 2000-2008 60
Table 32: Insulin Pens, Belgium, Volume (Units) by Sub-Segment, Forecast, 2008-2015 61
Table 33: Insulin Delivery, Belgium, Average Price ($), Historic, 2000-2008 62
Table 34: Insulin Delivery, Belgium, Average Price ($), Forecast, 2008-2015 62
Table 35: Insulin Delivery, Belgium, Distribution Share by Revenue ($mn), 2007-2008 63
Table 36: Insulin Delivery, Belgium, Company Share by Revenue ($ mn), 2007-2008 64
Table 37: Novo Nordisk A/S Pipeline Products by Equipment Type 72
Table 38: Novo Nordisk A/S Pipeline Products By Development Stage 72
Table 39: Novo Nordisk A/S Pipeline Products By Therapy Area 72
Table 40: Novo Nordisk A/S Pipeline Products By Clinical Trials 72
Table 41: Medtronic, Inc. Pipeline Products by Equipment Type 76
Table 42: Medtronic, Inc. Pipeline Products By Development Stage 78
Table 43: Medtronic, Inc. Pipeline Products By Therapy Area 80
Table 44: Medtronic, Inc. Pipeline Products By Clinical Trials 82
Table 45: Medtronic, Inc. Pipeline Products By News Summary 83
Table 46: LifeScan, Inc. Pipeline Products by Equipment Type 85
Table 47: LifeScan, Inc. Pipeline Products By Development Stage 85
Table 48: LifeScan, Inc. Pipeline Products By Therapy Area 86
Table 49: LifeScan, Inc. Pipeline Products By Clinical Trials 86
Table 50: LifeScan, Inc. Pipeline Products By News Summary 86
Table 51: F. Hoffmann-La Roche Ltd Pipeline Products by Equipment Type 89
Table 52: F. Hoffmann-La Roche Ltd Pipeline Products By Development Stage 90
Table 53: F. Hoffmann-La Roche Ltd Pipeline Products By Therapy Area 90
Table 54: Eli Lilly and Company Pipeline Products by Equipment Type 93
Table 55: Eli Lilly and Company Pipeline Products By Development Stage 94
Table 56: Eli Lilly and Company Pipeline Products By Therapy Area 94
Table 57: Eli Lilly and Company Pipeline Products By Clinical Trials 94
Table 58: Eli Lilly and Company Pipeline Products By News Summary 94
Table 59: Bayer HealthCare AG Pipeline Products by Equipment Type 99
Table 60: Bayer HealthCare AG Pipeline Products By Development Stage 100
Table 61: Bayer HealthCare AG Pipeline Products By Therapy Area 100
Table 62: Bayer HealthCare AG Pipeline Products By News Summary 100
Table 63: ARKRAY, Inc. Pipeline Products by Equipment Type 101
Table 64: ARKRAY, Inc. Pipeline Products By Development Stage 101
Table 65: ARKRAY, Inc. Pipeline Products By Clinical Trials 101
Table 66: ARKRAY, Inc. Pipeline Products By News Summary 102
Table 67: Abbott Laboratories Pipeline Products by Equipment Type 106
Table 68: Abbott Laboratories Pipeline Products By Development Stage 106
Table 69: Abbott Laboratories Pipeline Products By Therapy Area 106
Table 70: USD to Local Currency, Average Exchange Rate 2008 111

Note: Product cover images may vary from those shown
3 of 4

Terumo Corporation
Smiths Medical
Sanofi-Aventis
Novo Nordisk A/S
Medtronic, Inc.
LifeScan, Inc.
F. Hoffmann-La Roche Ltd.
Eli Lilly and Company
Becton, Dickinson and Company
Bayer HealthCare AG
ARKRAY, Inc.
Animas Corporation
Abbott Laboratories

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Medtronic, Inc.
  • TekniPlex Inc
  • Enable Injections LLC
  • Roche Diagnostics Ltd.
  • Dexcom Inc
  • Abbott Laboratories Ltd.